معرفی
Glen T. Schumock is the Dean of the College of Pharmacy and a Professor in the Department of Pharmacy Systems, Outcomes and Policy at the University of Illinois at Chicago (UIC). As Dean, he leads one of the top-ranked and largest pharmacy colleges in the United States. A licensed pharmacist with extensive research experience, his expertise spans pharmacoeconomics, pharmacoepidemiology, drug costs, drug safety, and pharmacy education.
Dr. Schumock's educational background includes:
- Bachelors of Pharmacy from Washington State University (1987)
- Doctor of Pharmacy from the University of Washington (1989)
- Masters of Business Administration from UIC (1994)
- PhD in Public Health Sciences - Pharmacoepidemiology from UIC (2012)
- Residency in Hospital Pharmacy from University of Washington Medical Center (1989)
- Fellowship in Hospital Pharmacy Administration from UIC (1992)
- Specialized Residency in Hospital Pharmacy Administration from UIC (1991)
Dr. Schumock's research focuses on pharmacoeconomics and pharmacoepidemiology, with particular emphasis on the cost and economic impact of prescription medications, medication safety, and adherence patterns. His work often examines real-world medication use patterns and their implications for healthcare systems. He has published extensively on national trends in prescription drug expenditures, with annual projections that are widely cited in the field. His methodological research on case-crossover studies has contributed significantly to understanding bias in pharmacoepidemiological research.
Analysis of Dr. Schumock's recent publications (2021-2025) reveals a consistent focus on pharmacoeconomics, medication adherence, and pharmacoepidemiological methods. His work spans multiple therapeutic areas including diabetes management (particularly SGLT2 inhibitors), HIV prevention (PrEP adherence), anticoagulation safety, and opioid-related risks. A notable pattern is his annual publication series on national prescription drug expenditure trends, which has become a standard reference in healthcare policy discussions. His research frequently employs sophisticated analytical methods including case-crossover designs, group-based trajectory modeling, and large claims database analyses.
Dr. Schumock has received numerous research grants including:
- Risk of Venous Thromboembolism Following Diagnosis and Treatment of Multiple Myeloma ($438,969, 2018-2019)
- Institute for Clinical and Economic Review Consulting Agreement ($500,000, 2017-2020)
- Sentinel Initiative with the Food and Drug Administration (2015-2020)
- Multiple grants related to Comparative Effectiveness Research totaling over $1 million
As an educator, Dr. Schumock teaches Undergraduate Research Experience in Pharmaceutical Systems (PSOP 300) and Dean's Leadership Forum (PMPR 329). His recent publication "Empowering Pharmacy Education: Leveraging Technology and Infrastructure to Advance Faculty, Staff and Student Success" (2024) demonstrates his commitment to advancing pharmacy education through technological innovation and infrastructure development.
